title: The sumatriptan difference.
authors.affiliation: Neurology Clinical Development and Product Strategy, Glaxo Smith Kline, USA.
authors.forename: R
authors.initials: R
authors.lastname: Salonen
mesh_terms: D000281:Administration, Intranasal; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008657:Metabolic Clearance Rate; D008881:Migraine Disorders / Q000188:drug therapy*; D018170:Sumatriptan / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D018170:Sumatriptan